Pricing Log in Create free account

Cyteir Therapeutics, Inc. (CYTT) vs Foghorn Therapeutics Inc. (FHTX)

Cyteir Therapeutics, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Cyteir Therapeutics, Inc. and Foghorn Therapeutics Inc. are of similar size ($112.2M and $108.7M). Cyteir Therapeutics, Inc. has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cyteir Therapeutics, Inc. leads on 8 and Foghorn Therapeutics Inc. on 4.

Valuation

Metric CYTT FHTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.56 9.71
P/B 0.87 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.55 0.24 0.64
EV/Sales n/m (0.46) 9.21
Earnings yield (31.23%) (52.97%) (33.15%)
Free cash flow yield (23.50%) (64.53%) (25.50%)

Profitability

Metric CYTT FHTX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (198.04%) 0.00%
Net margin 0.00% (175.78%) 0.00%
Free cash flow margin 0.00% (229.49%) 0.00%
Return on equity (23.80%) 81.90% (56.36%)
Return on assets (22.70%) (30.06%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYTT FHTX Biotechnology median
Revenue growth (TTM) — 51.98% 6.02%
EPS growth (last fiscal year) 39.35% 25.32% 30.26%
Revenue growth, 5-year CAGR — 135.14% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CYTT FHTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.89 3.36 4.72
Net debt to EBITDA 3.10 1.88 0.96

Dividend

Metric CYTT FHTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYTT FHTX Biotechnology median
Market cap 108.72m 112.24m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack